Species | Target name | Source | Bibliographic reference |
---|---|---|---|
Homo sapiens | dopamine beta-hydroxylase (dopamine beta-monooxygenase) | Starlite/ChEMBL | References |
Species | Potential target | Known druggable target/s | Ortholog Group |
---|---|---|---|
Schistosoma japonicum | ko:K00503 dopamine beta-monooxygenase [EC1.14.17.1], putative | Get druggable targets OG5_129281 | All targets in OG5_129281 |
Schistosoma mansoni | dopamine-beta-monooxygenase | Get druggable targets OG5_129281 | All targets in OG5_129281 |
Species | Potential target | Raw | Global | Species |
---|---|---|---|---|
Echinococcus multilocularis | nischarin | 0.0103297 | 0.17728 | 0.0629291 |
Plasmodium vivax | flavodoxin domain containing protein | 0.0257105 | 0.658914 | 0.872195 |
Schistosoma mansoni | cytochrome P450 reductase | 0.0280242 | 0.731365 | 1 |
Loa Loa (eye worm) | FAD binding domain-containing protein | 0.0181034 | 0.420705 | 0.474611 |
Plasmodium falciparum | nitric oxide synthase, putative | 0.0280242 | 0.731365 | 1 |
Entamoeba histolytica | type A flavoprotein, putative | 0.00992078 | 0.164474 | 0.5 |
Schistosoma mansoni | 5-methyl tetrahydrofolate-homocysteine methyltransferase reductase | 0.0181034 | 0.420705 | 0.474611 |
Leishmania major | cytochrome P450 reductase, putative | 0.0257105 | 0.658914 | 0.872195 |
Schistosoma mansoni | diflavin oxidoreductase | 0.0122345 | 0.236925 | 0.163802 |
Trypanosoma brucei | NADPH--cytochrome P450 reductase, putative | 0.0280242 | 0.731365 | 1 |
Loa Loa (eye worm) | flavodoxin family protein | 0.00992078 | 0.164474 | 0.0412714 |
Mycobacterium tuberculosis | Probable flavin-containing monoamine oxidase AofH (amine oxidase) (MAO) | 0.0340252 | 0.919283 | 0.5 |
Brugia malayi | FAD binding domain containing protein | 0.0181034 | 0.420705 | 0.575233 |
Trichomonas vaginalis | sulfite reductase, putative | 0.0280242 | 0.731365 | 1 |
Brugia malayi | flavodoxin family protein | 0.0280242 | 0.731365 | 1 |
Chlamydia trachomatis | sulfite reductase | 0.0181034 | 0.420705 | 0.5 |
Echinococcus multilocularis | NADPH cytochrome P450 reductase | 0.0280242 | 0.731365 | 1 |
Loa Loa (eye worm) | hypothetical protein | 0.0280242 | 0.731365 | 1 |
Entamoeba histolytica | type A flavoprotein, putative | 0.00992078 | 0.164474 | 0.5 |
Brugia malayi | flavodoxin family protein | 0.00992078 | 0.164474 | 0.224886 |
Mycobacterium ulcerans | flavin-containing monoamine oxidase AofH | 0.0366029 | 1 | 1 |
Echinococcus multilocularis | methionine synthase reductase | 0.0181034 | 0.420705 | 0.474611 |
Leishmania major | NADPH-cytochrome p450 reductase-like protein | 0.0280242 | 0.731365 | 1 |
Brugia malayi | FAD binding domain containing protein | 0.0280242 | 0.731365 | 1 |
Echinococcus multilocularis | NADPH dependent diflavin oxidoreductase 1 | 0.0280242 | 0.731365 | 1 |
Schistosoma mansoni | dopamine-beta-monooxygenase | 0.016782 | 0.379325 | 0.404629 |
Entamoeba histolytica | type A flavoprotein, putative | 0.00992078 | 0.164474 | 0.5 |
Treponema pallidum | flavodoxin | 0.00992078 | 0.164474 | 0.5 |
Trypanosoma brucei | NADPH--cytochrome P450 reductase, putative | 0.0280242 | 0.731365 | 1 |
Mycobacterium ulcerans | flavin-containing monoamine oxidase AofH | 0.0366029 | 1 | 1 |
Plasmodium vivax | NADPH-cytochrome p450 reductase, putative | 0.0280242 | 0.731365 | 1 |
Toxoplasma gondii | flavodoxin domain-containing protein | 0.0122345 | 0.236925 | 0.5 |
Echinococcus granulosus | NADPH cytochrome P450 reductase | 0.0280242 | 0.731365 | 1 |
Echinococcus granulosus | nischarin | 0.0103297 | 0.17728 | 0.0629291 |
Giardia lamblia | Hypothetical protein | 0.0257105 | 0.658914 | 0.5 |
Schistosoma mansoni | NADPH flavin oxidoreductase | 0.0157897 | 0.348254 | 0.35208 |
Trypanosoma cruzi | NADPH-dependent FMN/FAD containing oxidoreductase, putative | 0.0280242 | 0.731365 | 1 |
Toxoplasma gondii | flavodoxin domain-containing protein | 0.0122345 | 0.236925 | 0.5 |
Trichomonas vaginalis | NADPH fad oxidoreductase, putative | 0.0257105 | 0.658914 | 0.872195 |
Entamoeba histolytica | type A flavoprotein, putative | 0.00992078 | 0.164474 | 0.5 |
Trypanosoma brucei | NADPH-cytochrome p450 reductase, putative | 0.0280242 | 0.731365 | 1 |
Trypanosoma cruzi | cytochrome P450 reductase, putative | 0.0280242 | 0.731365 | 1 |
Brugia malayi | Copper type II ascorbate-dependent monooxygenase, C-terminal domain containing protein | 0.00914146 | 0.14007 | 0.191519 |
Echinococcus granulosus | NADPH dependent diflavin oxidoreductase 1 | 0.0280242 | 0.731365 | 1 |
Trypanosoma cruzi | cytochrome P450 reductase, putative | 0.0280242 | 0.731365 | 1 |
Onchocerca volvulus | Nischarin homolog | 0.0100246 | 0.167725 | 0.5 |
Entamoeba histolytica | type A flavoprotein, putative | 0.00992078 | 0.164474 | 0.5 |
Giardia lamblia | Nitric oxide synthase, inducible | 0.0257105 | 0.658914 | 0.5 |
Leishmania major | p450 reductase, putative | 0.0280242 | 0.731365 | 1 |
Trypanosoma brucei | NADPH-dependent diflavin oxidoreductase 1 | 0.0280242 | 0.731365 | 1 |
Loa Loa (eye worm) | FAD binding domain-containing protein | 0.0280242 | 0.731365 | 1 |
Echinococcus granulosus | methionine synthase reductase | 0.0181034 | 0.420705 | 0.474611 |
Brugia malayi | hypothetical protein | 0.0100246 | 0.167725 | 0.229331 |
Loa Loa (eye worm) | hypothetical protein | 0.0100246 | 0.167725 | 0.0467702 |
Brugia malayi | Copper type II ascorbate-dependent monooxygenase, C-terminal domain containing protein | 0.00914146 | 0.14007 | 0.191519 |
Trypanosoma cruzi | p450 reductase, putative | 0.0280242 | 0.731365 | 1 |
Activity type | Activity value | Assay description | Source | Reference |
---|---|---|---|---|
IC50 (functional) | = 1.7 uM | Cytotoxicity against human MRC5 cells | ChEMBL. | 25089179 |
IC50 (binding) | = 2 uM | Inhibition of dopamine beta-oxygenase (unknown origin) | ChEMBL. | 25089179 |
IC50 (functional) | = 2.2 uM | Cytotoxicity against mouse B16 cells | ChEMBL. | 25089179 |
IC50 (functional) | = 8.7 uM | Antimalarial activity against Plasmodium falciparum FCR-3/Gambia | ChEMBL. | 25089179 |
MIC (functional) | = 45 uM | Antibacterial activity against Escherichia coli NIHJ | ChEMBL. | 25089179 |
Species name | Source | Reference | Is orphan |
---|---|---|---|
Homo sapiens | ChEMBL23 | 25089179 | |
Mus musculus | ChEMBL23 | 25089179 | |
Plasmodium falciparum | ChEMBL23 | 25089179 |
Many chemical entities in TDR Targets come from high-throughput screenings with whole cells or tissue samples, and not all assayed compounds have been tested against a single a single target protein, probably because they get ruled out during screening process. Even if these compounds may have not been of interest in the original screening, they may come as interesting leads for other screening assays. Furthermore, we may be able to propose drug-target associations using chemical similarities and network patterns.
1 literature reference was collected for this gene.